Watch List for Traders: Southwest Airlines (NYSE:LUV), Healthcare Realty Trust (NYSE:HR), Forward Industries Inc. (NASDAQ:FORD), BIND Therapeutics (NASDAQ:BIND), Angie’s List (NASDAQ:ANGI)


Southwest Airlines Co. (NYSE:LUV) shares fell -0.34% in last trading session and ended the day at $32.51. LUV Gross Margin is 66.80% and its has a return on assets of 7.00%. Southwest Airlines Co. (NYSE:LUV) quarterly performance is -23.99%. Southwest Airlines Co. (NYSE:LUV) said it has reached a tentative agreement with its Flight Attendants. Terms of the deal were not released, but the airline said they include wage increases, bonus opportunities, and work-rule adjustments. Southwest Airlines Flight Attendants, represented by Transport Workers Union or TWU 556, will be presented with the details of the agreement in the coming weeks. Members will have the opportunity to vote on ratification.

Healthcare Realty Trust Incorporated (NYSE:HR) caters to the Financial space. It has a net profit margin of 9.80% and weekly performance is 1.46%. On the last day of trading company shares ended up $23.62. Healthcare Realty Trust Incorporated (NYSE:HR) distance from 50-day simple moving average (SMA50) is -2.95%. Healthcare Realty Trust Incorporated (NYSE:HR) announced that on June 30, 2015, the Company sold two single-tenant net lease properties totaling 176,000 square feet in Indianapolis, Indiana for $97.0 million. The properties include a 118,000 square foot orthopedic inpatient surgical hospital and an attached 58,000 square foot medical office building.

On 02 July, Forward Industries Inc. (NASDAQ:FORD) shares increased 4.69% and was closed at $0.67. FORD EPS growth in last 5 year was 15.00%. Forward Industries Inc. (NASDAQ:FORD) year to date (YTD) performance is -35.58%. Forward Industries Inc. (NASDAQ:FORD) announced the appointment of Terence Wise, who presently serves as the Company’s Chairman of the Board of Directors, as Chief Executive Officer of the Company and Michael Matte as Chief Financial Officer of the Company, following the expiration of Michael Luetkemeyer’s term as Interim CEO. Messrs. Wise and Matte will assume their appointments with immediate effect. In addition, the Board of Directors announced the appointment of Scott Fine as Lead Director of the Board and Dr. Sharon Hrynkow as a new director of the Board.

BIND Therapeutics, Inc. (NASDAQ:BIND) shares increased 1.07% in last trading session and ended the day at $5.66. BIND has a return on assets of -49.40%. BIND Therapeutics, Inc. (NASDAQ:BIND) quarterly performance is 2.54%. On June 23, BIND Therapeutics, Inc. (NASDAQ:BIND) announced that the U.S. Food and Drug Administration (FDA) has authorized the use of AstraZeneca’s Accurin AZD2811 in clinical trials under an investigational new drug (IND) application. BIND is collaborating with AstraZeneca on the development of AZD2811, an Aurora B Kinase inhibitor that has been shown to be active in both solid and hematological tumors in preclinical models, and the companies anticipate enrolling patients in a phase 1 clinical trial with AZD2811 in the fourth quarter of this year. BIND will earn a $4 million milestone payment upon first dosing a patient in a phase 1 clinical trial with AZD2811.

Angie’s List, Inc. (NASDAQ:ANGI) caters to the Technology space. It has a net profit margin of -1.20% and weekly performance is -2.73%. On the last day of trading company shares ended up $6.41. Angie’s List, Inc. (NASDAQ:ANGI) distance from 50-day simple moving average (SMA50) is 2.86%. Angie’s List Inc. on Wednesday said it named Chief Operating Officer J. Mark Howell as interim chief executive. The online review site’s former chief executive, co-founder Bill Oesterle, had said in April that he would step down to become “more involved” with civic issues in Indiana.


Leave a Reply

Your email address will not be published. Required fields are marked *